267 related articles for article (PubMed ID: 6101312)
1. Effects of nadolol beta-blockade on blood pressure in hypertension.
Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
[TBL] [Abstract][Full Text] [Related]
2. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
[TBL] [Abstract][Full Text] [Related]
3. Nadolol compared to propranolol for treating chronic stable angina pectoris.
Miller LA; Crawford MH; O'Rourke RA
Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
[TBL] [Abstract][Full Text] [Related]
4. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
Wilcox RG; Hampton JR
Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
[No Abstract] [Full Text] [Related]
7. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
[TBL] [Abstract][Full Text] [Related]
9. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
[TBL] [Abstract][Full Text] [Related]
10. Nadolol eye drops in glaucoma and ocular hypertension: a controlled clinical study of dose response and duration of action.
Krieglstein GK
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):309-14. PubMed ID: 6119925
[TBL] [Abstract][Full Text] [Related]
11. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
Danesh BJ; Brunton J; Sumner DJ
Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
[No Abstract] [Full Text] [Related]
13. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
Weth G; Schneider J; Rodatz H; Haubitz I
Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
[TBL] [Abstract][Full Text] [Related]
14. The comparative effects of ICI 118551 and propranolol on essential tremor.
Jefferson D; Wharrad HJ; Birmingham AT; Patrick JM
Br J Clin Pharmacol; 1987 Dec; 24(6):729-34. PubMed ID: 2894217
[TBL] [Abstract][Full Text] [Related]
15. A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.
Hornung RS; Gould BA; Kieso H; Raftery EB
Br J Clin Pharmacol; 1982 Jul; 14(1):83-8. PubMed ID: 6125200
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of hypotensive effect of nadolol].
Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
[No Abstract] [Full Text] [Related]
17. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
18. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
[TBL] [Abstract][Full Text] [Related]
19. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Freis ED
Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
[TBL] [Abstract][Full Text] [Related]
20. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
